Vriestran 1mg/100mg Injection
Marketer
Taj Pharma India Ltd
Salt Composition
Vincristine (1mg) + Mannitol (100mg)
Overview Vriestran 1mg/100mg Injection
Oncasol 1mg/100mg Injection, a prescription medication, combines two active agents for the treatment of diverse cancers, including those affecting the breast, lungs, ovaries, and pancreas. Its mechanism inhibits cancerous cell growth and proliferation, leading to tumor regression. Administered by a healthcare professional (doctor or nurse), Oncasol 1mg/100mg Injection may be used as monotherapy or in conjunction with other drugs as part of a comprehensive treatment plan. Dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Continue treatment as directed by your doctor. Common side effects include sleep disturbances (insomnia), tiredness (fatigue), elevated temperature (fever), febrile neutropenia, low red blood cell count (anemia), and nausea. Report any concerning or severe side effects to your doctor; management strategies may be available. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and provide a complete list of all medications currently being taken. Pregnant or breastfeeding individuals must consult their physician before using this injection.
Uses of Vriestran 1mg/100mg Injection
Malignant neoplasm
Major Benefits of Vriestran 1mg/100mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Vriestran 1mg/100mg Injection:
- Insomnia (difficulty in sleeping)
- Fatigue
- Fever
- Febrile neutropenia
- Anemia (low number of red blood cells)
- Nausea
- Constipation
- Diarrhea
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Decreased appetite
How to use Vriestran 1mg/100mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Vriestran 1mg/100mg Injection works:
Vriestran Injection (1mg/100mg) unites vincristine, an antineoplastic agent, with mannitol. Vincristine's mechanism involves disrupting DNA and RNA replication, crucial for cancerous cell proliferation. Mannitol facilitates vincristine's penetration of the blood-brain barrier, enabling its action against brain tumors.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vriestran 1mg/100mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Vriestran 1mg/100mg Injection in pregnancy is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Vriestran 1mg/100mg Injection with breastfeeding are lacking. Seek your physician's advice.
DrivingCONSULT YOUR DOCTOR
The effect of Vriestran 1mg/100mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Vriestran 1mg/100mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Vriestran 1mg/100mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Vriestran 1mg/100mg Injection :
Omit a Vriestran 1mg/100mg Injection dose? Seek medical advice immediately.
Facts to Know About Vriestran 1mg/100mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently